Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
MedTech
J&J CEO says M&A strategy to 'continue' after medtech megadeals
After inking more than $30 billion in M&A within two years, CEO Joaquin Duato said that strategy will continue as it hunts for long-term growth.
Conor Hale
Apr 16, 2024 1:42pm
Ten members of FDA's TriClip panel had financial ties to Abbott
Apr 10, 2024 10:25am
Medtronic’s head-to-head TAVR study shows benefits among women
Apr 9, 2024 12:26pm
NewAmsterdam shares more data on lipid-lowering Amgen castoff
Apr 9, 2024 5:30am
J&J's Abiomed pump reduces deaths after widowmaker heart attacks
Apr 8, 2024 12:12pm
GE HealthCare brings coaching software to hand-held ultrasound
Apr 8, 2024 10:01am